Company intelligence / Profile preview

Built Biotechnologies

New Castle, Delaware, United States

Ownership: Private
Development stage: Preclinical

Overview

Built Biotechnologies offers a centralized, subscription-based platform specializing in the rapid and reliable construction of long and complex custom DNA constructs. The company addresses key bottlenecks in advanced molecular biology by providing high-quality synthetic DNA to support research and product development in cell therapy, gene therapy, and broader biotechnology sectors. Early access programs are underway with select partners.

Modalities: DNA construct manufacturing (enabling technology for cell and gene therapy, synthetic biology, etc.)
Industry: Drug Discovery Services

Partnerships

Early access partnerships with select innovators in biotech sector during initial rollout phase (specific names not disclosed as of June 2025)

Beyond the preview

Go deeper on Built Biotechnologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Built Biotechnologies.

Explore the full profile